Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 1, 2005
Previous Article Next Article

Genomics and the second golden era of cancer drug development

Author affiliations

Abstract

The first golden era of cancer drug development was initiated in the 1940s and gave rise to the cytotoxic agents that dominate current cancer medicine. The second golden era is now underway in which cancer genomics will direct drug development.

Graphical abstract: Genomics and the second golden era of cancer drug development

Back to tab navigation

Publication details

The article was received on 02 Feb 2005, accepted on 14 Mar 2005 and first published on 30 Mar 2005


Article type: Highlight
DOI: 10.1039/B501751N
Citation: Mol. BioSyst., 2005,1, 17-26

  •   Request permissions

    Genomics and the second golden era of cancer drug development

    P. Workman, Mol. BioSyst., 2005, 1, 17
    DOI: 10.1039/B501751N

Search articles by author

Spotlight

Advertisements